Chemotherapy and Targeted Therapy in Advanced Biliary Tract Carcinoma: A Pooled Analysis of Clinical Trials

Publisher： Karger

E-ISSN： 1421-9794|60|1|13-23

ISSN： 0009-3157

Source： Chemotherapy, Vol.60, Iss.1, 2014-10, pp. : 13-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma

By  

Chemotherapy, Vol. 56, Iss. 3, 2010-06 ,pp. : 234-238

Karger

Access to resources Recommend Favorite

Targeted Therapy for Biliary Tract Cancer

By Furuse Junji   Okusaka Takuji  

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2243-2254

MDPI

Access to resources Recommend Favorite

Prospective Phase II Trial of Gemcitabine in Combination with Irinotecan as First-Line Chemotherapy in Patients with Advanced Biliary Tract Cancer

By  

Chemotherapy, Vol. 57, Iss. 3, 2011-05 ,pp. : 236-243

Karger

Access to resources Recommend Favorite

Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer

By  

Chemotherapy, Vol. 60, Iss. 2, 2015-02 ,pp. : 91-98

Karger

Access to resources Recommend Favorite

Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Single-Center Study

By  

Chemotherapy, Vol. 58, Iss. 3, 2012-07 ,pp. : 225-232

Karger

Access to resources Recommend Favorite